Cleo Diagnostics Ltd (ASX:COV)

Cleo Diagnostics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023
Cash & Equivalents	7.31	9.37	0.24
Cash & Short-Term Investments	7.31	9.37	0.24
Cash Growth	-27.67%	3809.00%	-
Accounts Receivable	-	0.06	-
Other Receivables	0.08	-	0.03
Receivables	0.08	0.06	0.03
Prepaid Expenses	0.08	0.01	0.31
Total Current Assets	7.48	9.44	0.58
Property, Plant & Equipment	0.03	0.03	0.04
Other Intangible Assets	0.38	0.41	0.46
Total Assets	7.89	9.88	1.08
Accounts Payable	0.39	0.25	0.31
Accrued Expenses	0.06	0.05	0
Short-Term Debt	-	-	1.6
Other Current Liabilities	-	0.19	0.1
Total Current Liabilities	0.45	0.49	2.02
Total Liabilities	0.45	0.49	2.02
Common Stock	13.71	13.71	0.05
Retained Earnings	-7.48	-5.53	-1.77
Comprehensive Income & Other	1.22	1.22	0.78
Shareholders' Equity	7.44	9.39	-0.94
Total Liabilities & Equity	7.89	9.88	1.08
Total Debt	-	-	1.6
Net Cash (Debt)	7.31	9.37	-1.36
Net Cash Per Share	0.07	0.08	-0.05
Filing Date Shares Outstanding	128.5	128.5	44.09
Total Common Shares Outstanding	128.5	128.5	44.09
Working Capital	7.03	8.95	-1.44
Book Value Per Share	0.06	0.07	-0.02
Tangible Book Value	7.06	8.98	-1.4
Tangible Book Value Per Share	0.05	0.07	-0.03
Machinery	-	0.04	0.04

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.